Atlas Trials

A 12-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Painful Peripheral Neuropathy

Clinical trial NCT04786340 · COMPLETED

Trial details

NCT number
NCT04786340
Sponsor
WinSanTor, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Painful Diabetic NeuropathyDiabetes Mellitus
Start date
2020-11-20
Primary completion
2022-12-08
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.